We are international
Donate
TEXT SIZE   

Call the IMF Hotline. We are here for you. The IMF Office is open from 9:00 - 5:00 PT on Monday-Friday.

If you have a question, call the IMF Hotline at (800) 452-CURE (800-452-2873) in the US and Canada. The hotline is open from 9:00 - 4:00 PT Monday - Friday. Elsewhere call (818) 487-7455. You can also contact us via the web.
IMF - Home Page
    next      view all

New!! Understanding Adherence to Oral Cancer Therapy

Understanding Adherence to Oral Cancer Therapy is intended to help myeloma patients and their healthcare providers work together to overcome any and all obstacles to adherence to safe and effective oral cancer therapy.


Physicians from China Attend IMF's Groundbreaking Myeloma Master Class

The IMF welcomes physicians from China's top medical institutions to the IMF's 2nd annual Myeloma Master Class.


Check out Dr. Durie's new blog - "On the Subject of Cancer and Diet: My Interview with BBC Radio"

The Patients Equal Access Coalition Applauds a New Bill to Improve Access to Oral Cancer Drugs
The federal Cancer Drug Coverage Parity Act will dramatically improve the lives of cancer patients. Patients who previously could not afford these treatments will be able to access their life‐saving effects. It will also make cancer treatments more practical for patients living in rural and underserved areas by reducing the need to drive long distances for a nurse or doctor to administer treatment.

Black Swan Research Initiative FAQs. The what, how and why of this exciting new effort.
As the Black Swan Research Initiative™ team moves from its launch phase to its research phase, we will update this page frequently with new information. Be sure to check back often in the coming months.

The IMF went to Kyoto for the IMW. Let Dr. Durie explain it all to you.

IMF Advocates Join Thousands Rallying for Medical Research Support
The IMF was proud to be among several thousand researchers and patient advocates who gathered in Washington, D.C. on Monday, April 8, to protest cuts to biomedical research.

FDA Fast Tracks Daratumumab for Double Refractory Myeloma

Myeloma Awareness Month went viral!

Questions about Black Swan Research Initiative? Dr. Durie's blog can help with that...

    next      view all